Attenuation of temporary focal cerebral ischemic injury in the mouse following transfection with interleukin-1 receptor antagonist

Molecular Brain Research

Volumn 72, Issue 2, 1999, Pages 129-137

  Yang, Guo Yuan ^a   Mao, Ying ^a,c   Zhou, Liang Fu ^c   Ye, Wen ^a   Liu, Xiao Hong ^a   Gong, Chao ^a   Lorris Betz, A ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c FUDAN UNIVERSITY   (China)

Author keywords

Adenovirus; Blood brain barrier; Interleukin 1; Intracellular adhesion molecule 1; Ischemia; Mouse; Temporary

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; GENETIC TRANSFECTION; INFLAMMATION; LASER DOPPLER FLOWMETRY; LEUKOCYTE ADHERENCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

ADENOVIRIDAE; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; CYTOKINES; GENE THERAPY; GENETIC VECTORS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LASER-DOPPLER FLOWMETRY; MALE; MICE; NERVE TISSUE PROTEINS; RECOMBINANT FUSION PROTEINS; REPERFUSION INJURY; SIALOGLYCOPROTEINS; TRANSFECTION;

ADENOVIRIDAE;

EID: 0032825443     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(99)00205-3     Document Type: Article

References (48)

1. Albayrak S., Zhao Q., Siesjo B.K., Smith M.L. Effect of transient focal ischemia on blood-brain barrier permeability in the rat: correlation to cell injury. Acta Neuropathologica. 94:1997;158-163.
2. Betz A.L., Schielke G.P., Yang G.Y. Interleukin-1 in cerebral ischemia. Keio J. Med. 45:1996;230-237.
3. Betz A.L., Yang G.Y., Davidson B.L. Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J. Cereb. Blood Flow Metab. 15:1995;547-551.
4. Blatteis C.M. Neuronal mechanisms in the pyrogenic and acute phase responses to interleukin-1. Int. J. Neurosci. 38:1988;223-232.
5. Choi D.W. Ischemia-induced neuronal apoptosis. Curr. Opin. Neurobiol. 6:1996;667-672.
6. DiBona D.R., Powell W.J.J. Quantitative correlation between cell swelling and necrosis in myocardial ischemia in dogs. Circ. Res. 47:1980;653-665.
7. C.A. Dinarello, The biology of interleukin-1, in: T. Kishimoto (Ed.), Interleukins: Molecular Biology and Immunology, Karger, Basel, Switzerland, 1992, pp. 1-32.
8. Dinarello C.A. The role of interleukin-1 in host responses to infectious diseases. Infectious Agents and Disease. 1:1992;227-236.
9. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood. 87:1996;2095-2147.
10. Dinarello C.A., Thompson R.C. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunology Today. 12:1991;404-410.
11. Farooqui A.A., Horrocks L.A. Excitatory amino acid receptors, neuronal membrane phospholipid metabolism and neurological disorders. Brain. Res. Rev. 16:1992;171-191.
12. Feuerstein G.Z., Liu T., Barone F.C. Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha. Cerebrovasc. Brain Metab. Rev. 6:1994;341-360.
13. K.B.J. Franklin, Paxinos G., The mouse brain in stereotaxic coordinates, 1997, pp. 20-40.
14. Garcia J.H., Liu K.-F., Yoshida Y., Lian J., Chen S., del Zoppo G. Influx of leukocytes and platelets in an evolving brain infarct. Am. J. Pathol. 144:1994;188-199.
15. Garcia J.H., Lui K.F., Relton J.K. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am. J. Pathol. 147:1995;1477-1486.
16. Giulian D., Woodward J., Young D.G., Krebs J.F., Lachman L.B. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J. Neurosci. 8:1988;2485-2490.
17. Hallenbeck J.M., Dutka A.J. Background review and current concepts of reperfusion injury. Arch. Neurol. 47:1990;1245-1254.
18. Hara H., Fink K., Endres M., Friedlander R.M., Gagliardini V., Yuan J., Moskowitz M.A. Attenuation of transient focal cerebral ischemic injury in transgenic mice expressing a mutant ICE inhibitory protein. J. Cereb. Blood Flow Metab. 17:1997;370-375.
19. Krawisz J.E., Sharon P., Stenson W.F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology. 87:1984;1344-1350.
20. Levy D.E., van Uitert R.L., Pike C.L. Delayed postischemic hypoperfusion: a potentially damaging consequence of stroke. Neurology. 29:1979;1245-1252.
21. Loberg E.M., Hassel B., Fonnum F., Torvik A. Early entry of plasma proteins into damaged neurons in brain infarcts. An immunohistochemical study on experimental animals. Apmis. 102:1994;771-776.
22. Matsuo Y., Onodera H., Shiga Y., Nakamura M., Ninomiya M., Kihara T., Kogura K. Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat: effects of neutrophil depletion. Stroke. 25:1994;1469-1475.
23. Matsuo Y., Onodera H., Shiga Y., Shozuhara H., Ninomiya M., Kihara T., Tamatani T., Miyasaka M., Kogura K. Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat. Brain Res. 656:1994;344-352.
24. Mori E., del Zoppo G.J., Chambers D., Copeland B.R., Arfors K.E. Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons. Stroke. 23(5):1992;712-718.
25. Okada Y., Copeland B.R., Mori E., Tung M.M., Thomas W.S., del Zoppo G.J. P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke. 25:1994;202-211.
26. Onodera H., Yamasaki Y., Matsuo Y. Ischemia and neuroimmunology - ischemia/reperfusion injury. Nippon Rinsho. 52:1994;2995-2999.
27. Rao A.M., Baskaya M.K., Maley M.E., Kindy M.S., Dempsey R.J. Beneficial effects of S-adenosyl-L-methionine on blood-brain barrier breakdown and neuronal survival after transient cerebral ischemia in gerbils. Brain Res. Mol. Brain Res. 44:1997;134-138.
28. Relton J.K., Martin D., Russell D. Effects of peripheral IL-1ra treatment after focal cerebral ischemia in the rat. Soc. Neurosci. 19:1993;6732.
29. Roessler B.J., Hartman J.W., Vallance D.K., Latta J.M., Janich S.L., Davidson B.L. Inhibition of IL-1 induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector. Hum. Gene Ther. 6:1995;307-316.
30. Romson J.L., Hook B.G., Kunkel S.L., Abrams G.D., Schork M.A., Lucchesi B.R. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation. 67:1983;1016-1023.
31. Rowe G.T., Manson N.H., Caplan M., Hess M.L. Hydrogen peroxide and hydroxyl radical mediation of activated leukocyte depression of cardiac sarcoplasmic reticulum. Circ. Res. 53:1983;584-591.
32. Schielke G.P., Yang G.Y., Shivers B.D., Betz A.L. Reduced ischemic brain injury in interleukin-1 beta converting enzyme-deficient mice. J. Cereb. Blood Flow. Metab. 18:1998;180-185.
33. Schleien C.L., Eberle B., Shaffner D.H., Koehler R.C., Traystman R.J. Reduced blood-brain barrier permeability after cardiac arrest by conjugated superoxide dismutase and catalase in piglets. Stroke. 25:1994;1830-1834.
34. Siesjo B.K., Siesjo P. Mechanisms of secondary brain injury. Eur. J. Anaesthesiol. 13:1996;247-268.
35. Strieter R.M., Kunkel S.L., Showell H.J. Endothelial cell gene expression of a neutrophil chemotactic factor by TNFα, LPS, and IL-1β Science. 243:1989;1467-1469.
36. Swanson R.A., Morton M.T., Tsao W.G., Savalos R.A., Davidson C., Sharp F.R. A semiautomated method for measuring brain infarct volume. J. Cereb. Blood Flow Metab. 10(2):1990;290-293.
37. Tasdemiroglu E., Christenberry P.D., Ardell J.L., Chronister R.B., Taylor A.E. Effects of antioxidants on the blood-brain barrier and postischemic hyperemia. Acta Neurochir. 131:1994;302-309.
38. Tomita M., Fukuuchi Y. Leukocytes, macrophages and secondary brain damage following cerebral ischemia. Acta Neurochir. 66:1996;32-39.
39. Wang X., Feuerstein G.Z. Induced expression of adhesion molecules following focal brain ischemia. J. Neurotrauma. 12:1995;825-832.
40. Wong D., Dorovini Zis K. Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide. J. Neuroimmunol. 39:1992;11-22.
41. Yang G.Y., Betz A.L., Hoff J.T. The effects of blood or plasma clot on brain edema in the rat with intracerebral hemorrhage. Acta Neurochir. 60(Suppl):1994;555-557.
42. Yang G.Y., Chan P.H., Chen J., Carlson E., Chen S.F., Weinstein P., Epstein C.J., Kamii H. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke. 25:1994;165-170.
43. G.Y. Yang, C. Gong, Z. Qin, Y. Mao, X. Liu, A.L. Betz, Tumor necrosis factor alpha expression is associated with increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice, Brain Res. Mol. Brain Res. (1998) in press.
44. Yang G.Y., Zhao Y., Davidson B.L., Betz A.L. Overexpression of interleukin-1 receptor antagonist in the mouse brain reduces ischemic brain injury. Brain Res. 751:1997;181-188.
45. Zhang J., Benveniste H., Klitzman B., Piantadosi C.A. Nitric oxide synthase inhibition and extracellular glutamate concentration after cerebral ischemia/reperfusion. Stroke. 26:1995;298-304.
46. Zhang R.L., Chopp M., Li Y., Zaloga C., Jiang N., Jone M., Miyasaka M., Ward P. Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Neurology. 44:1994;1747-1751.
47. Zhang R.L., Chopp M., Zaloga C., Zhang Z.G., Jiang N., Gautam S.C., Tang W.X., Tsang W., Anderson D.C., Manning A.M. The temporal profiles of ICAM-1 protein and mRNA expression after transient MCA occlusion in the rat. Brain Res. 682:1995;182-188.
48. Zuckerman S.L., Mirro R., Armstead W.M., Shibata M., Leffler C.W. Indomethacin reduces ischemia-induced alteration of blood-brain barrier transport in piglets. Am. J. Physiol. 266:1994;H2198-2203.